Mayo Clinic Proceedings Home

Predictors of Omega-3 Index in Patients With Acute Myocardial Infarction


      To identify the patient and dietary characteristics associated with low omega-3 levels in patients with acute myocardial infarction (AMI) and determine whether these characteristics are useful to identify patients who may benefit from omega-3 testing and treatment.


      Dietary habits of 1487 patients in the 24-center Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients' Health status (TRIUMPH) registry between April 11, 2005, and September 28, 2007, were assessed by asking about the frequency of fast food and nonfried fish consumption. All patients had erythrocyte omega-3 index measured at the time of hospital admission for AMI. We used multivariable linear regression to identify independent correlates of the omega-3 index and modified Poisson regression to predict risk of a low omega-3 index (<4%).


      The proportion of patients with a low omega-3 index increased with more frequent fast food intake (18.9% for <1 time monthly, 28.6% for 1-3 times monthly, 28.8% for 1-2 times weekly, and 37.6% for ≥3 times weekly; P<.001). In contrast, a low omega-3 index was less common among patients with more frequent fish intake (35.1% for <1 time monthly, 24.9% for 1-3 times monthly, 16.1% for 1-2 times weekly, and 21.1% for ≥3 times weekly; P<.001). Fish intake, older age, race other than white, and omega-3 supplementation were independently associated with a higher omega-3 index, whereas frequent fast food intake, smoking, and diabetes mellitus were associated with a lower omega-3 index.


      Potentially modifiable factors, such as patient-reported fast food intake, fish intake, and smoking, are independently associated with the omega-3 index in patients with AMI. These characteristics may be useful to identify patients who would benefit most from omega-3 supplementation and lifestyle modification.
      AMI (acute myocardial infarction), DHA (docosahexaenoic acid), EPA (eicosapentaenoic acid), RBC (red blood cell), TRIUMPH (Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients' Health status)
      To read this article in full you will need to make a payment


      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Harris WS
        • Poston WC
        • Haddock CK
        Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events.
        Atherosclerosis. 2007; 193: 1-10
        • Pottala JV
        • Garg S
        • Cohen BE
        • Whooley MA
        • Harris WS
        Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul study.
        Circ Cardiovasc Qual Outcomes. 2010; 3: 406-412
        • Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico
        Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial.
        Lancet. 1999; 354: 447-455
        • Wang C
        • Harris WS
        • Chung M
        • et al.
        n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review.
        Am J Clin Nutr. 2006; 84: 5-17
        • Tavazzi L
        • Maggioni AP
        • Marchioli R
        • et al.
        Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-Hf trial): a randomised, double-blind, placebo-controlled trial.
        Lancet. 2008; 372: 1223-1230
        • Sands SA
        • Reid KJ
        • Windsor SL
        • Harris WS
        The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes.
        Lipids. 2005; 40: 343-347
        • Block RC
        • Harris WS
        • Pottala JV
        Determinants of blood cell omega-3 fatty acid content.
        Open Biomark J. 2008; 1: 11-16
        • Harris WS
        • Von Schacky C
        The Omega-3 Index: a new risk factor for death from coronary heart disease?.
        Prev Med. 2004; 39: 212-220
        • Block RC
        • Harris WS
        • Reid KJ
        • Sands SA
        • Spertus JA
        EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls.
        Atherosclerosis. 2008; 197: 821-828
        • Zou G
        A modified Poisson regression approach to prospective studies with binary data.
        Am J Epidemiol. 2004; 159: 702-706
        • Hosmer DW
        • Lemeshow S
        Applied Logistic Regression. John Wiley and Sons, Inc, New York, NY2000
        • Kris-Etherton PM
        • Harris WS
        • Appel LJ
        Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease.
        Circulation. 2002; 106: 2747-2757
        • Kromhout D
        • Giltay EJ
        • Geleijnse JM
        n-3 fatty acids and cardiovascular events after myocardial infarction.
        N Engl J Med. 2010; 363: 2015-2026
        • Food and Nutrition Board, Institute of Medicine
        Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fat, Protein and Amino Acids (Macronutrients). National Academies Press, Washington, DC2005
        • Rauch B
        • Schiele R
        • Schneider S
        • et al.
        OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction.
        Circulation. 2010; 122: 2152-2159